PMID- 19155346 OWN - NLM STAT- MEDLINE DCOM- 20090707 LR - 20191210 IS - 1542-6270 (Electronic) IS - 1060-0280 (Linking) VI - 43 IP - 2 DP - 2009 Feb TI - Human papillomavirus vaccine safety in pediatric patients: an evaluation of the Vaccine Adverse Event Reporting System. PG - 356-9 LID - 10.1345/aph.1L492 [doi] AB - Recent news reports have linked the human papillomavirus (HPV) vaccine to serious adverse events (AEs) in children and adolescents. We used the Vaccine Adverse Event Reporting System (VAERS) database to extract postmarketing AEs reported in patients who received the vaccine. Since approval of the HPV vaccine in the US, 3174 AEs occurring in children and adolescents (aged 6-17 y) have been reported to the VAERS. Of these, 191 (6%) were deemed to be serious. Although these AEs are of significant concern, more research is required before they can be directly correlated with the vaccine. FAU - Borja-Hart, Nancy L AU - Borja-Hart NL AD - College of Pharmacy, Nova Southeastern University, Ft. Lauderdale, FL 33328, USA. nborja@nova.edu FAU - Benavides, Sandra AU - Benavides S FAU - Christensen, Crystal AU - Christensen C LA - eng PT - Evaluation Study PT - Journal Article DEP - 20090120 PL - United States TA - Ann Pharmacother JT - The Annals of pharmacotherapy JID - 9203131 RN - 0 (Papillomavirus Vaccines) SB - IM MH - Adolescent MH - *Adverse Drug Reaction Reporting Systems MH - Child MH - Clinical Trials as Topic MH - Female MH - Guillain-Barre Syndrome/etiology MH - Humans MH - Papillomavirus Vaccines/*adverse effects MH - Pulmonary Embolism/etiology MH - Seizures/etiology MH - Stroke/etiology MH - Venous Thrombosis/etiology EDAT- 2009/01/22 09:00 MHDA- 2009/07/08 09:00 CRDT- 2009/01/22 09:00 PHST- 2009/01/22 09:00 [entrez] PHST- 2009/01/22 09:00 [pubmed] PHST- 2009/07/08 09:00 [medline] AID - aph.1L492 [pii] AID - 10.1345/aph.1L492 [doi] PST - ppublish SO - Ann Pharmacother. 2009 Feb;43(2):356-9. doi: 10.1345/aph.1L492. Epub 2009 Jan 20.